This is an archive of papers published by the staff and faculty of Fox Chase Cancer Center. For questions about content, please contact Talbot Research Library
Last updated on
Sauter ER , Ehya H , Klein-Szanto AJP , Wagner-Mann C , MacGibbon B
Fiberoptic ductoscopy findings in women with and without spontaneous nipple discharge
Cancer. 2005 Mar 1;103(5) :914-921
AbstractBACKGROUND. Fiberoptic ductoscopy (FD), which allows direct visualization of the breast ductal lumen, is performed in women with and without spontaneous nipple discharge (SND). Previous reports suggested that cytologic evaluation of SND may be falsely interpreted as containing malignancy. The purpose of the Current Study, which was performed prospectively, was to determine whether ductoscopic findings were different in women with versus without SND, and to assess the implications of the differences in SND versus non-SND samples regarding the role of FD in assessing whether a woman has breast carcinoma.METHODS. Data were collected on the distance traveled by the ductoscope, Visual observations, pathology, cytology, epithelial and foam cell quantity, and image analysis for ploidy, hypertetraploidy, and S-phase fraction.RESULTS. Of 100 FD specimens, 60 were from breasts without SND and 40 were from breasts with SND. Intraductal visual observations (P less than or equal to 0.000 2), pathologic findings in the resected specimen (P less than or equal to 0.001), zinc quantity of epithelial cells (P = 0.03) were influenced by the presence or absence of SND. Although one specimen from a benign breast was interpreted as cytologically malignant, every breast with both malignant cytology and aneuploidy contained cancer cells. A model incorporating cytology and SND was 92% sensitive and 60% specific in predicting which women had breast carcinoma.CONCLUSIONS. There were pronounced differences in FD samples from women with and without SND. FD biologic parameters can be chosen to optimize breast carcinoma predictive sensitivity and specificity. SND cytology can present a diagnostic problem, suggesting the need for histologic confirmation before the initiation of therapy. Cancer 2005;103:914-21. (C) 2005 American Cancer Society.